Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nihon Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that specializes in the development, manufacture, and sale of plasma-derived medicinal products and gastrointestinal treatments. As a core subsidiary of Takeda Pharmaceutical Company, it plays a vital role in the Japanese healthcare system by providing essential blood products such as albumin and immunoglobulins. The company's portfolio also includes diagnostic agents and specialized treatments for hepatic diseases, notably ammonia-lowering agents for hepatic encephalopathy. Nihon Pharmaceutical operates advanced manufacturing facilities in Narita and Izumisano, maintaining high standards for plasma fractionation and protein purification. Its business is characterized by a strong commitment to the stable supply of life-saving therapies derived from human plasma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nihon Pharmaceutical Industry.